Coca-Cola clarified that Coke Zero and Diet Coke do not contain the sugar replacement called erythritol but instead have aspartame.
According to Coca-Cola’s official website, aspartame is used in some of its products including Coke Zero Sugar, Diet Coke, Diet Coke Feisty Cherry, Diet Barq’s, Fanta Zero, Fresca, Gold Peak Diet Tea, Mello Yello Zero, Minute Maid Light, Pibb Zero, Seagrams Ginger Ale Zero Sugar, and Sprite Zero.
Aspartame provides low or no sugar calories option.
Unlike erythritol, aspartame hasn’t been linked with any serious side effects or health problems.
A recent study draws attention to the harmful effects of erythritol such as linked to causing serious health issues, including the risk of stroke, blood clotting, and heart attack
Erythritol reportedly used to “add bulk or sweeten monk fruit and keto reduced-sugar products.
According to Peace Health, one of the names for sugar alcohols used in foods labeled "sugar-free" or "no sugar added" is erythritol.
It is regarded as having calories and carbohydrates even if it is labeled as "sugar-free". It is said to have negative effects on persons who already have other underlying medical issues because it can raise blood sugar levels.
Erythritol is found naturally in some foods like wine, beer, and even cheese when they ferment.


The American mass exodus to Canada amid Trump 2.0 has yet to materialize
China Imposes 55% Tariff on Beef Imports Above Quota to Protect Domestic Industry
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
Grok AI Controversy on X Sparks Global Outrage Over Nonconsensual Images
Stuck in a creativity slump at work? Here are some surprising ways to get your spark back
China Manufacturing PMI Rebounds in December, Offering Boost to Economic Growth Outlook
Novo Nordisk Launches Once-Daily Wegovy Pill in U.S. at Competitive Pricing
Trump Blocks HieFo’s Emcore Chip Assets Deal Over National Security Concerns
Every generation thinks they had it the toughest, but for Gen Z, they’re probably right
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease
L3Harris Nears $500M Deal to Sell Majority Stake in Space Propulsion Portfolio to AE Industrial
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
Asian Markets Slip as Precious Metals Cool, Geopolitical Tensions Weigh on Sentiment
Debate over H-1B visas shines spotlight on US tech worker shortages
South Korea Inflation Rises to 2.3% in December, Matching Market Expectations
Samsung to Double AI-Powered Mobile Devices with Google Gemini in Global AI Race 



